Aaron Seth Kesselheim, M.D.
This page shows the publications co-authored by Aaron Kesselheim and Mehdi Najafzadeh.
Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition Unclear. Health Aff (Millwood). 2021 05; 40(5):772-778.
Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984-2018: an evaluation of Food and Drug Administration flexibilities. Lancet Infect Dis. 2020 07; 20(7):e159-e164.
Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012. JAMA Intern Med. 2018 11 01; 178(11):1458-1466.
Cost to Medicare of Delayed Adalimumab Biosimilar Availability. Clin Pharmacol Ther. 2021 10; 110(4):1050-1056.
Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis. BMJ. 2019 07 17; 366:l4257.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.